Continuity of TB services during the COVID-19 pandemic in China

This article has been Reviewed by the following groups

Read the full article

Abstract

No abstract available

Article activity feed

  1. SciScore for 10.1101/2020.07.16.20150292: (What is this?)

    Please note, not all rigor criteria are appropriate for all manuscripts.

    Table 1: Rigor

    Institutional Review Board Statementnot detected.
    Randomizationnot detected.
    Blindingnot detected.
    Power Analysisnot detected.
    Sex as a biological variablenot detected.

    Table 2: Resources

    No key resources detected.


    Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).


    Results from LimitationRecognizer: We detected the following sentences addressing limitations in the study:
    There were clearly documented limitations in available TB services caused by the response to COVID-19 and other movement restrictions likely led to further barriers for probable TB patients to access diagnosis and care. Further, although our survey does not document this phenomenon, it seems likely that concerns about SARS-CoV-2 transmission in health facilities and on public transportation may have prevented individuals from seeking TB diagnosis or care. The impact of COVID-19 on the health system and the potential for COVID-19 responses to undermine TB control efforts are already clear. This pandemic presents difficult challenges for national and local TB programs and suggests a need to understand how to ensure that COVID-19 responses disrupt TB services as little as possible. Based on these hospitals’ experiences, we propose two specific recommendations: Timely modification of TB services: To mitigate the impact of COVID-19 on TB care and control, national and local TB programs should commit to interventions which can maintain the continuity of essential services for TB patients. For example, provision of adequate stocks of medicines for all TB patients can ensure treatment completion without unnecessary hospital visits to collect medications. As China and many other high TB burden countries remain reliant on in-person and community-based DOTS for TB treatment, modification of current in-person TB services in preference for more innovative patient-centered approaches may i...

    Results from TrialIdentifier: No clinical trial numbers were referenced.


    Results from Barzooka: We did not find any issues relating to the usage of bar graphs.


    Results from JetFighter: We did not find any issues relating to colormaps.


    Results from rtransparent:
    • Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
    • Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
    • No protocol registration statement was detected.

    About SciScore

    SciScore is an automated tool that is designed to assist expert reviewers by finding and presenting formulaic information scattered throughout a paper in a standard, easy to digest format. SciScore checks for the presence and correctness of RRIDs (research resource identifiers), and for rigor criteria such as sex and investigator blinding. For details on the theoretical underpinning of rigor criteria and the tools shown here, including references cited, please follow this link.